Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes

Background: Treatment decisions after diagnosis of clinically localized prostate cancer are difficult due to variability in tumor behavior. As there is a high prevalence of low-grade prostate cancer with an indolent course, we need improved markers of prostate cancer lethality in order to reduce the...

Full description

Saved in:
Bibliographic Details
Main Author: Sumaira Siddiqui
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-04-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:https://journals.lww.com/10.4103/ijpm.ijpm_171_22
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825205473272397824
author Sumaira Siddiqui
author_facet Sumaira Siddiqui
author_sort Sumaira Siddiqui
collection DOAJ
description Background: Treatment decisions after diagnosis of clinically localized prostate cancer are difficult due to variability in tumor behavior. As there is a high prevalence of low-grade prostate cancer with an indolent course, we need improved markers of prostate cancer lethality in order to reduce the overtreatment. In the current study, we assessed Ki-67 expression in cases of prostate carcinoma and correlated its expression with clinical outcomes. Materials and Methods: It was a single-center retrospective descriptive type of study. A total of 50 cases were included. Diagnosed cases of adenocarcinoma on Transurethral Resection of the Prostate (TURP) chips and Trucut prostatic biopsies (Archival biopsy specimens) for whom five years follow-up was available from record files and/or telephonic interviews were included. The clinical outcomes (rate of distant metastases, disease specific survival, and overall survival) over a period of five years were recorded. Results: In the current study, 78% of the cases of carcinoma prostate were positive for Ki-67 expression. The mean Ki-67 staining index was 15.22% among the cases. The cases with High Ki-67 Staining index had a significantly higher rate of distant metastasis, poor disease-specific survival, and overall survival compared to cases with low Ki-67 staining index. Conclusion: Ki-67 can be used along with the other established prognostic parameters to assess the lethality of prostate cancer.
format Article
id doaj-art-b25751c1e910402080bc3bfe5015e2f9
institution Kabale University
issn 0377-4929
0974-5130
language English
publishDate 2024-04-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pathology and Microbiology
spelling doaj-art-b25751c1e910402080bc3bfe5015e2f92025-02-07T13:57:54ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49290974-51302024-04-0167236236610.4103/ijpm.ijpm_171_22Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomesSumaira SiddiquiBackground: Treatment decisions after diagnosis of clinically localized prostate cancer are difficult due to variability in tumor behavior. As there is a high prevalence of low-grade prostate cancer with an indolent course, we need improved markers of prostate cancer lethality in order to reduce the overtreatment. In the current study, we assessed Ki-67 expression in cases of prostate carcinoma and correlated its expression with clinical outcomes. Materials and Methods: It was a single-center retrospective descriptive type of study. A total of 50 cases were included. Diagnosed cases of adenocarcinoma on Transurethral Resection of the Prostate (TURP) chips and Trucut prostatic biopsies (Archival biopsy specimens) for whom five years follow-up was available from record files and/or telephonic interviews were included. The clinical outcomes (rate of distant metastases, disease specific survival, and overall survival) over a period of five years were recorded. Results: In the current study, 78% of the cases of carcinoma prostate were positive for Ki-67 expression. The mean Ki-67 staining index was 15.22% among the cases. The cases with High Ki-67 Staining index had a significantly higher rate of distant metastasis, poor disease-specific survival, and overall survival compared to cases with low Ki-67 staining index. Conclusion: Ki-67 can be used along with the other established prognostic parameters to assess the lethality of prostate cancer.https://journals.lww.com/10.4103/ijpm.ijpm_171_22disease-specific survivaldistant metastasiski-67overall survivalprostatic cancer
spellingShingle Sumaira Siddiqui
Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes
Indian Journal of Pathology and Microbiology
disease-specific survival
distant metastasis
ki-67
overall survival
prostatic cancer
title Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes
title_full Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes
title_fullStr Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes
title_full_unstemmed Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes
title_short Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes
title_sort assessment of ki 67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes
topic disease-specific survival
distant metastasis
ki-67
overall survival
prostatic cancer
url https://journals.lww.com/10.4103/ijpm.ijpm_171_22
work_keys_str_mv AT sumairasiddiqui assessmentofki67expressionincasesofprostaticcarcinomaanditscorrelationwithclinicaloutcomes